BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26296479)

  • 1. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.
    Sharma P; Katzka DA; Gupta N; Ajani J; Buttar N; Chak A; Corley D; El-Serag H; Falk GW; Fitzgerald R; Goldblum J; Gress F; Ilson DH; Inadomi JM; Kuipers EJ; Lynch JP; McKeon F; Metz D; Pasricha PJ; Pech O; Peek R; Peters JH; Repici A; Seewald S; Shaheen NJ; Souza RF; Spechler SJ; Vennalaganti P; Wang K
    Gastroenterology; 2015 Nov; 149(6):1599-606. PubMed ID: 26296479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett's oesophagus and stage I oesophageal adenocarcinoma.
    di Pietro M; Trudgill NJ; Vasileiou M; Longcroft-Wheaton G; Phillips AW; Gossage J; Kaye PV; Foley KG; Crosby T; Nelson S; Griffiths H; Rahman M; Ritchie G; Crisp A; Deed S; Primrose JN
    Gut; 2024 May; 73(6):897-909. PubMed ID: 38553042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Controlled Study on Clinical Adherence to Evidence-Based Guidelines in the Management of Simulated Patients With Barrett's Esophagus and the Clinical Utility of a Tissue Systems Pathology Test: Results From Q-TAB.
    Peabody JW; Cruz JDC; Ganesan D; Paculdo D; Critchley-Thorne RJ; Wani S; Shaheen NJ
    Clin Transl Gastroenterol; 2024 Jan; 15(1):e00644. PubMed ID: 37767993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in diagnosis and management of cancer of the esophagus.
    Deboever N; Jones CM; Yamashita K; Ajani JA; Hofstetter WL
    BMJ; 2024 Jun; 385():e074962. PubMed ID: 38830686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrett's Esophagus and Associated Dysplasia.
    Patil DT; Odze RD
    Gastroenterol Clin North Am; 2024 Mar; 53(1):1-23. PubMed ID: 38280743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's adenocarcinoma of the esophagus: better outcomes through new methods of diagnosis and treatment.
    Behrens A; Pech O; Graupe F; May A; Lorenz D; Ell C
    Dtsch Arztebl Int; 2011 May; 108(18):313-9. PubMed ID: 21629515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research.
    Abrams JA; Appelman HD; Beer DG; Berry LD; Chak A; Falk GW; Fitzgerald RC; Ginsberg GG; Grady WM; Joshi BP; Lynch JP; Markowitz S; Richmond ES; Rustgi AK; Seibel EJ; Shaheen NJ; Shyr Y; Umar A; Wang KK; Wang TC; Wang TD; Yassin R
    Gastroenterology; 2014 Jun; 146(7):1586-90. PubMed ID: 24768332
    [No Abstract]   [Full Text] [Related]  

  • 8. Estimated Burden of Screening for Barrett's Esophagus in the United States.
    Chandar AK; Low EE; Singer ME; Yadlapati R; Singh S
    Gastroenterology; 2023 Jul; 165(1):283-285.e2. PubMed ID: 37001765
    [No Abstract]   [Full Text] [Related]  

  • 9. Measuring and improving quality in esophageal care and swallowing disorders.
    Reddy AT; Lee JP; Leiman DA
    Dis Esophagus; 2024 Jun; 37(6):. PubMed ID: 38458618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSP-9: A Barrett's Esophagus Biomarker Better Than Pathologists?
    Rubenstein JH; Stachler MD
    Gastroenterology; 2023 Nov; 165(5):1106-1107. PubMed ID: 37659675
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments on "TSP-9: A Barrett's Esophagus Biomarker Better Than Pathologists?".
    Duits LC; Critchley-Thorne RJ; Bergman JJGHM
    Gastroenterology; 2024 Apr; 166(4):714-715. PubMed ID: 38109947
    [No Abstract]   [Full Text] [Related]  

  • 12. A Delphi Method for Development of a Barrett's Esophagus Question Prompt List as a Communication Tool for Optimal Patient-physician Communication.
    Kamal AN; Wang CJ; Triadafilopoulos G; Diehl DL; DuCoin C; Dunst CM; Falk G; Iyer PG; Katzka DA; Konda VJA; Muthusamy R; Otaki F; Pleskow D; Rubenstein JH; Shaheen NJ; Sharma P; Smith MS; Sujka J; Swanstrom LL; Tatum RP; Trindade AJ; Ujiki M; Wani S; Clarke JO
    J Clin Gastroenterol; 2024 Feb; 58(2):131-135. PubMed ID: 36753462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.
    Kountourakis P; Ajani JA; Davila M; Lee JH; Bhutani MS; Izzo JG
    Gastrointest Cancer Res; 2012 Mar; 5(2):49-57. PubMed ID: 22690258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2022 top 10 list of endoscopy topics in medical publishing: an annual review by the American Society for Gastrointestinal Endoscopy Editorial Board.
    Mulki R; Qayed E; Yang D; Chua TY; Singh A; Yu JX; Bartel MJ; Tadros MS; Villa EC; Lightdale JR
    Gastrointest Endosc; 2023 Dec; 98(6):1009-1016. PubMed ID: 37977661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus.
    Wolf WA; Pasricha S; Cotton C; Li N; Triadafilopoulos G; Muthusamy VR; Chmielewski GW; Corbett FS; Camara DS; Lightdale CJ; Wolfsen H; Chang KJ; Overholt BF; Pruitt RE; Ertan A; Komanduri S; Infantolino A; Rothstein RI; Shaheen NJ
    Gastroenterology; 2015 Dec; 149(7):1752-1761.e1. PubMed ID: 26327132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus.
    El-Serag HB; Naik AD; Duan Z; Shakhatreh M; Helm A; Pathak A; Hinojosa-Lindsey M; Hou J; Nguyen T; Chen J; Kramer JR
    Gut; 2016 Aug; 65(8):1252-60. PubMed ID: 26311716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.
    Shaheen NJ; Falk GW; Iyer PG; Gerson LB;
    Am J Gastroenterol; 2016 Jan; 111(1):30-50; quiz 51. PubMed ID: 26526079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial predisposition of dysplasia in Barrett's esophagus segments: a pooled analysis of the SURF and AIM dysplasia trials.
    Cotton CC; Duits LC; Wolf WA; Peery AF; Dellon ES; Bergman JJ; Shaheen NJ
    Am J Gastroenterol; 2015 Oct; 110(10):1412-9. PubMed ID: 26346864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX2 as a novel marker to predict neoplastic progression in Barrett's esophagus.
    van Olphen S; Biermann K; Spaander MC; Kastelein F; Steyerberg EW; Stoop HA; Bruno MJ; Looijenga LH
    Am J Gastroenterol; 2015 Oct; 110(10):1420-8. PubMed ID: 26323187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with refractory reflux symptoms: What do they have and how should they be managed?
    Kahrilas PJ; Keefer L; Pandolfino JE
    Neurogastroenterol Motil; 2015 Sep; 27(9):1195-201. PubMed ID: 26303047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.